MR5-23062-95428
5 vaccinations
2 coded responses
61 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 021 / MA
- Registered
- 2021-03-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-20
Registered in v-safe
-
2021-03-20
Dose 1 — Pfizer-BioNTech
- 2021-03-20
-
2021-03-21
Survey response — days 1–6 daily, dose 1MedDRA: Affect lability, Confusional state, Migraine — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Confusion, emotional disregulation (most severe the evening after my morning vaccination. May have been synergistic with migraine/post-migraine symptoms.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-04-03
- 2021-04-10
-
2021-04-11
Dose 2 — Pfizer-BioNTech
- 2021-04-11
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-18
- 2021-04-25
- 2021-05-02
- 2021-05-09
- 2021-05-16
- 2021-05-23
- 2021-07-11
- 2021-10-10
-
2021-10-14
Dose 3 — Pfizer-BioNTech
-
2021-10-17
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-10-18
- 2021-10-19
- 2021-10-20
- 2021-10-21
- 2021-10-28
- 2021-11-04
- 2021-11-11
- 2021-11-18
- 2021-11-25
- 2022-01-13
-
2022-04-16
Survey response — 6 months, dose 3MedDRA: Raynaud's phenomenon, Vasospasm — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Reynauds-like vasospasmMedDRA releases: 2024-11 · check-in free text available
-
2022-04-16
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-05-22
Dose 4 — Moderna
- 2022-05-22
-
2022-05-23
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Swelling · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend schoolAdult check-in
- 2022-05-24
- 2022-05-25
- 2022-05-26
- 2022-05-27
- 2022-05-29
- 2022-06-05
- 2022-06-13
- 2022-06-19
- 2022-06-26
- 2022-07-03
- 2022-08-21
-
2022-09-07
Dose 5 — Moderna
-
2022-09-08
Health check-in — days 1–6 daily, dose 5Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-09-10
- 2022-09-11
- 2022-09-12
- 2022-09-16
- 2022-09-21
- 2022-09-28
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-12-07
- 2023-03-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-20 | Pfizer-BioNTech | |
| 2 | 2021-04-11 | Pfizer-BioNTech | |
| 3 | 2021-10-14 | Pfizer-BioNTech | No |
| 4 | 2022-05-22 | Moderna | No |
| 5 | 2022-09-07 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Confusion, emotional disregulation (most severe the evening after my morning vaccination. May have been synergistic with migraine/post-migraine symptoms.
Release 11 — 6 months, dose 3
Symptoms: Reynauds-like vasospasm
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Raynaud's phenomenon | · | · | ✓ |
| SD | Vasospasm | · | · | ✓ |
| SRO | Affect lability | ✓ | ✓ | ✓ |
| SRO | Confusional state | ✓ | ✓ | ✓ |
| SRO | Migraine | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release